Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Delayed Toronto S.E.
Other stock markets
 15:51:26 26/06/2024 BST 		5-day change 1st Jan Change
0.53 CAD 0.00% Intraday chart for Satellos Bioscience Inc. -3.64% +23.26%
05-28 Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment MT
05-28 Satellos Bioscience Inc. Brief: Announcing Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy MT

Evolution of the average Target Price on Satellos Bioscience Inc.

Price target over the last 5 years

History of analyst recommendation changes

5328f91e28877d1f8d3a29871b.-UEFoC5yTLaBZYF-YXYg0AxSTUmzkXpG1fPHnk8TcDg.mhltwU0BJvu4EscrKwZFl2MaBgDn0hMZmKyv3wNFBErIDlOYFh8j08UjzA~6e52fbaadef5e12458baf94a1b396219

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.53 CAD
Average target price
1.2 CAD
Spread / Average Target
+126.42%
High Price Target
1.2 CAD
Spread / Highest target
+126.42%
Low Price Target
1.2 CAD
Spread / Lowest Target
+126.42%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Consensus Satellos Bioscience Inc.